A whistleblower lawsuit against Medtronic Inc. that highlighted perks allegedly paid to doctors was filed by one of the company's lawyers, according to a report today in the Wall Street Journal. The legal action was ultimately settled in 2006 for $40 million.
The 2002 suit, filed by former senior legal counsel Ami P. Kelley, claimed the Fridley-based medical technology giant lavished spine surgeons with a variety of incentives to use its products, including regular entertainment at a Memphis strip club, trips to Alaska and patent royalties on inventions they played no part in.
The allegations involve the relationship between Medtronic's spine business and doctors. Sen. Charles Grassley, the ranking member of the Senate Finance Committee, is investigating these relationships, which have also been the focus of at least two other whistleblower lawsuits filed by former employees.
Grassley has been looking into whether perks offered by Medtronic to doctors induce them to use the company's spine products in "off-label" ways not approved by the Food and Drug Administration (FDA). The FDA has warned that surgeons' off-label use of a Medtronic bone graft called Infuse has led to potentially life-threatening side effects in dozens of patients.
Medtronic said in a statement Thursday that the relationship between the medical device industry and physicians is fundamental to device therapy innovation. In addition, doctors provide valuable training and education on new devices, which benefits patients, the company said.
"Because Medtronic understands there is a potential physician conflict of interest, these relationships must be appropriately managed and publicly transparent," according to the statement.
Kelley's lawsuit, filed in U.S. District Court in Memphis against the company and 10 doctors, remains sealed, except for a heavily redacted copy of the original complaint, which contains none of the doctors' names, according to the Journal. Federal law prohibits companies from giving doctors inducements to use products covered by Medicare or Medicaid.
Medtronic declined to comment on the lawsuit's allegations because the suit remains sealed. But in its statement, the company said it took the investigation "extremely seriously and cooperated fully with the Department of Justice. Behaviors like those described in the [Wall Street Journal] article are inconsistent with Medtronic's ethical standards."